Yahoo Web Search

Search results

1. • Study reveals insights into DDX41 protein's role in blood cancer pathogenesis

     Medical Xpress· 3 days ago

     A study led by Professors Hongtae Kim and JaYil Lee from the Department of Biological Sciences, in collaboration with researchers from the Catholic University of Korea, sheds light on the pivotal ...

2. • 

     Chandler community rallying around toddler who needs life-saving bone marrow transplant

     KTVK 3TV Phoenix· 6 days ago

     Family and friends are rallying around a toddler who is battling cancer, hoping he will soon receive...

3. • 

     Arthritis linked to blood cancer mutations

     Medical Xpress· 3 days ago

     The research focused on seronegative rheumatoid arthritis, a sub-type of the more common rheumatoid arthritis (RA), that differs in the inconsistency of...

4. • MEI Pharma (NASDAQ:MEIP) Research Coverage Started at StockNews.com

     ETF DAILY NEWS· 6 days ago

     Investment analysts at StockNews.com assumed coverage on shares of MEI Pharma (NASDAQ:MEIP – Get Free Report) in a note issued to investors on Sunday. The firm set a “buy” rating on the stock ...

5. • 

     CAR-T Plus Stem-Cell Transplant Promising for CD7+ Blood Cancers

     MedPage Today· 3 days ago

     A strategy of sequential CD7 chimeric antigen receptor (CAR) T-cell therapy and haploidentical...

6. • ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest...

     Morningstar· 2 days ago

     SUZHOU, China and ROCKVILLE, Md., April 24, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis ...

7. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 1 day ago

     SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will

8. • Kura Oncology Gets Breakthrough Designation For Leukemia Therapy

     Market Watch· 4 days ago

     The San Diego-based biopharmaceutical company said the U.S. Food and Drug Administration had granted ziftomenib the status as a potential treatment for relapsed/refractory NPM1-mutant

9. • MD Anderson Research Highlights for April 24, 2024

     Newswise· 3 days ago

     The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These adva

10. • 

      I left my daughter's dad 4 years ago and have zero interest in reentering the dating world

      INSIDER via Yahoo News· 5 days ago

      When she was six months old, I asked him to leave. During those tough months, doctors diagnosed my...